Omeprazole sodium

Omeprazole Sodium (CAS 95510-70-6) is the sodium salt form of omeprazole, a proton pump inhibitor belonging to the benzimidazole class. It is also referenced under the names Omeprazole Sodium Salt and H 168/68 sodium. No E-code designation applies to this substance.

In pharmaceutical manufacturing, omeprazole sodium serves as the active pharmaceutical ingredient in injectable and intravenous formulations, where the sodium salt form provides the aqueous solubility required for parenteral delivery. It functions by irreversibly binding to the gastric H+/K+-ATPase enzyme, suppressing gastric acid secretion at the source. It is also used as a reference standard and intermediate in API synthesis and analytical method development.

Omeprazole sodium is supplied to pharmaceutical manufacturers in grades aligned with Ph.Eur. and USP pharmacopoeial standards. The substance falls under REACH regulation and requires appropriate handling documentation. Procurement quantities are available in laboratory and bulk formats, with packaging suited to its hygroscopic nature.